Feldman S, Zhang J, Martinez D, et al. Real-world treatment patterns of biologics, apremilast among patients with moderate to severe plaque psoriasis by metabolic syndrome status [abstract L11]. J Manag Care Spec Pharm. 2019, 25(suppl 10-a):S78. doi: 10.18553/jmcp.2019.25.10-a.s1.
Advertisement
Articles by Feldman S, Zhang J, Martinez D, et al. Real-world treatment patterns of biologics, apremilast among patients with moderate to severe plaque psoriasis by metabolic syndrome status [abstract L11]. J Manag Care Spec Pharm. 2019, 25(suppl 10-a):S78. doi: 10.18553/jmcp.2019.25.10-a.s1.
Advertisement
Latest Updated Articles
- Abstract Recap: Real-World Treatment Patterns Among Patients With Moderate to Severe Plaque Psoriasis by Metabolic Syndrome Status
Published: December 6th 2019 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
2
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
3
Making the Genetic Models Match the Ancestry of Patient Populations
4
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
5
